Greetings and welcome to WEAVE's fourth quarter and full year 2025 financial results in conference call. At this time, all participants are on a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. If you would like to ask a question, please raise your hand. If you have dialed in to today's call, please press star 9 to raise your hand and star 6 to unmute. I would now like to turn the conference over to your host, Moriah Shilton, Investor Relations. Thank you. You may begin.

Thank you, Kevin. Good afternoon, everyone, and welcome to Weave's fourth quarter and full year 2025 Financial Results Conference Call. With me on today's call are Brett White, CEO, and Jason Christensen, CFO. During the course of this conference call, we will make forward-looking statements regarding the anticipated performance of our business. These forward-looking statements are based on management's current views and expectations, entail certain assumptions made as of today's date, and are subject to various risks and uncertainties described in our SEC filing. We leave disclaims any obligation to update or revise any forward-looking statements. Further, on today's call, we will also discuss certain non-GAAP metrics that we believe aid in the understanding of our financial results. unless otherwise noted all numbers we talk about today will be on a non-GAAP basis which excludes one-time acquisition related costs amortization of acquired intangible assets and stock-based compensation a reconciliation to comparable gap metrics can be found in today's earnings release which is available on our investor relations website and as an exhibit to the form 8k furnished with the sec before this call as well as the earnings presentation on our investor relations website before i turn the call over to brett we want to let you know that we'll be participating in the raymond james institutional investors conference on march 2nd at the jw marriott in orlando florida and with that i will now turn the call over to

brett thank you mariah and thank you to everyone joining us today we've delivered another strong quarter in Q4. With 17% year-over-year revenue growth, gross margin expanding to a company record of 73.3%, and operating income increasing to $2.3 million, our highest level both in dollars and as a percentage of revenue. This marks the 16th consecutive quarter of meeting or exceeding the high end of our revenue guidance range. For the full year, we generated 17% revenue growth and 24% growth in free cash flow. These results demonstrate the strength of our model, consistent Tomlite top line growth, expanding margins and disciplined cash generation while continuing to advance the platform for our customers. We're proving we can scale profitably and deliver new capabilities that deepen Weave's value to the practice. At our core, we serve the professionals who care for patients. Our customers provide care at every stage of life from the first pediatric visits to restorative procedures, chronic care management, and everything in between. They are trusted professionals delivering essential services in their communities. Healthcare is fundamentally human. AI will not replace providers, it will amplify them. What it can do, and what we are building toward, is removing the administrative friction that pulls people away from patients. Our vision is simple, elevate patient experiences through a unified platform that improves business operations so healthcare professionals can focus on patient care. This vision is not a slogan. It guides how we build, invest, and operate. The healthcare industry is one of the largest and most complex in the world, making it ripe for AI adoption. SMB practices have historically been slow to embrace digital transformation. Healthcare professionals navigate increasing administrative burdens like staffing shortages, rising patient demand and reimbursement complexity. They require technology solutions to manage growth, communication, schedules, billing, insurance and payments so they can focus on the patient in front of them while staying competitive in the local markets. Missed patient calls, scheduling challenges and shifting insurance dynamics waste time, reduce patient satisfaction, increase burnout, and strain practice revenue and profitability. These operational inefficiencies create a clear and durable opportunity for automation and value creation. That's where WEAVE comes in. WEAVE is the unified AI-powered patient communications and engagement platform purpose-built for small and medium-sized healthcare practices. We bring together AI agent and practice staff conversations across voice and text into unified workflows. Weave is the orchestration layer that helps practices continuously improve patient relationships, proactively assigns tasks for staff follow-up, and delivers insights so practice owners can measure, analyze, and optimize. Weave is a mission-critical practice system of work. built at the center of patient interactions 24-7. All conversations flow through Weave, creating operational data to drive process continuity inside our platform. This continuity extends across communication channels. The patient conversation can begin on the phone, continue over text with an AI agent, and escalate back to a staff member when needed. Our platform treats this as a single, persistent interaction, preserving context end-to-end, so patient requests are addressed sufficiently. This is coordinated teamwork between the Weave AI platform and the practice staff we support. Weave is powered by authorized secure integrations with practice management systems, making our platform reliable enough to manage scheduling, insurance verification, billing, and payments. This goes well beyond responding to basic inquiries. As customers continue to recognize the value of our agentic workflows, Weave evolves from a product that practices use to an always-on teammate they rely on. We reduce administrative burden, improve conversion and collections, and free staff to focus on high-value patient care. Most importantly, we strengthen the patient-practice relationship, which ultimately drives more revenue and profitability for our customers. With communication history, automation, and real-time performance insights all in Weave, practices run smarter, grow faster, and build lasting operational resilience. Customer reliance on Weave makes our platform indispensable, strengthening customer retention, expanding share of wallet, increasing customer lifetime value, as we continuously add value through AI-powered solutions and additional products that our customers demand. We believe that AI will augment software companies that leverage and deliver its value. This is especially true in vertical, highly regulated markets like healthcare, where moats and years of expertise matter. Weave has spent almost two decades building for the unique needs of SMB healthcare practices. Healthcare workflows are highly customized. Scheduling, billing, insurance verification, and patient communication vary by specialty and by location. Delivering reliable AI-powered workflows in these environments requires authorized integrations with systems of record, regulatory compliance, scalability, and predictable execution. Most importantly, it requires trust with providers and patients. With almost 40,000 customer locations and billions of patient interactions flowing through our platform annually, we have the data mode at scale that cannot be replicated by horizontal generative AI providers. Our extensive industry-specific data allows us to deliver high accuracy without exposing PHI. This domain expertise and trusted data foundation are durable competitive advantages. Our customers are healthcare providers, not technologists. Doctor owners are focused on delivering care and running their businesses. They do not have the time, resources, or desire to build and maintain custom applications, particularly in an industry that has historically lagged in digitization and monetization. And that is the huge opportunity for Weave. Practices operate within strict privacy, security, and regulatory frameworks. They look to trusted software partners to navigate that complexity. Weave integrates with the practice management system, utilizes the trusted practice phone number, owns the phone hardware and telephony stack, and is deeply embedded in daily operations. We have yet to encounter a customer or prospect planning to replace that infrastructure with a homegrown solution. Instead, practices are seeking greater automation inside the systems that they already rely on. The acquisition of Trulark added an AI receptionist to our offering, embedding agentic functionality directly into our platform. Our capabilities go beyond reactive automation to deliver proactive execution, scheduling appointments, verifying insurance eligibility, collecting payments, identifying coaching opportunities, analyzing outcomes, and escalating to staff for full conversational context is preserved. This further establishes Weave's role as a system of work inside the practice. Additionally, we recognize that AI has the potential to disrupt some software revenue models, such as seat-based licensing. However, we license per location and based on consumption, not per seat. In fact, headcount reductions in a practice lead to even higher usage and dependency on the Weave platform. As we add agentic solutions to handle additional workflows, we capture share of wallet from the practice's labor budget, historically allocated to administrative staff or call centers. This simultaneously reduces practice costs and improves ROI. Adding isolated AI tools does not reduce the cost or complexity of running a healthcare practice. As AI becomes table stakes, the premium shifts to platforms that can act, not just in form. Weave is uniquely positioned to be that platform. Turning to our plans for 2026, Trulark is the foundational building block of our AI receptionist capabilities. Trulark accelerated our roadmap by adding an established tech-based AI agent that handles common FAQs, manages inbound leads, and automates scheduling and rebooking. The acquisition materially expanded our TAM by extending Weave deeper into the front office automation and directly addressing the single largest component of the practice's cost structure, staffing. This is both the biggest expense and one of the most operationally complex challenges practice owners face. One of our largest customers is now booking over 1,200 appointments per month using our AI receptionist, work that would otherwise require full-time front desk staff or just be missed. As that customer put it, quote, when you're thinking of software cost to cut, it is one of the last things you will ever consider because it is one of the few things that actually is bringing in revenue to the business, end quote. In Q4, we launched a unified inbox that consolidates TrueLark agentic conversations and weaves staff interactions into a single contextual view, removing the need to toggle between systems. We continued building voice capabilities, enabling the same AI agent to operate across text and phone. In the first half of 2026, we expect general availability of our omnichannel AI receptionist across all vertical markets. This enables practices to answer calls 24-7 with an AI agent that can address common questions, request or book appointments, and intelligently hand off more complex interactions to staff when needed. These conversations are transcribed and posted into our unified inbox, preserving full context across both AI agent and staff interactions. Weave Call Intelligence then automatically prioritizes important requests and creates follow-up tasks. In the second half of 2026, we plan to extend beyond scheduling to more autonomous intake and payments, including automated payment requests after claims adjudication and the collection of co-pays and pre-treatment deposits directly within scheduling flows. This is a deliberate phased rollout with a larger opportunity to expand AI across front and back office workflows. We are excited about the opportunity ahead in 2026. Our AI roadmap expands our TAM, deepens Weave's role in the practice, and leverages our market-leading position and scale. Before Jason dives into the financials, I wanted to recap a couple additional highlights from our 2025 growth vectors. The specialty medical vertical continues to stand out as one of our most attractive growth opportunities this space grew to become our second largest vertical by location count in q2 of 25. that momentum continued and we added more specialty location specialty medical locations in q4 than in any quarter in our history specialty medical comprises 29 specialties and we currently focused on just four primary care physical and occupational therapy aesthetics and med spa next weave payments grew at more than twice the rate of total revenue in 2025 with strong early adoption of new capabilities like automatic automated payment reminders bulk collections and surcharging today we announced a partnership agreement with care credit the leading patient financing solution used by over 285 000 health and wellness locations nationwide. This integration is expected to give Weave customers greater visibility into available patient credit, streamline the credit application process, and improve treatment acceptance rates by making care more accessible. In conclusion, Weave delivered consistent revenue growth, expanded margins, and free cash flow while continuing to invest in innovation. Just as importantly, the customer successes we see today give us confidence that this value creation is repeatable and sustainable. Weave is defining the intelligent healthcare front office. We're building a durable, scalable business that delivers on our commitments and we are excited about the long-term value we can create for both our customers and our shareholders. Both myself and the Weave management team entered 2026 very excited about not only opportunity ahead of us but also our very unique position to capitalize on the opportunities and deliver additional value to our markets I want to thank our customers partners team members and shareholders for your continued trust and weave the progress we've made gives a strong confidence in the path ahead with that I'll turn the call over to Jason for a deeper

discussion of our financial performance thanks Brett good afternoon everyone it was another solid quarter in a strong finish to the year for weave reflecting continued momentum in our growth initiatives and disciplined execution across the business. The growth in our product suite this year, including the acquisition of TrueLark, expanded our estimated total addressable market by roughly seven billion dollars to an estimated 22 billion dollars. We believe there is further TAM expansion on the horizon as we add capabilities to our AI receptionist. Across our established verticals, we see a meaningful runway for continued growth in dental our initial market we are in fewer than 15 percent of US locations highlighting the depth of opportunities still ahead for example we has recently been selected and endorsed by the American Dental Association as its exclusive patient engagement solution giving us co- marketing access to their hundred and sixty thousand members and reinforcing our leadership position in the dental market. Specialty Medical is our largest and newest US market opportunity and we remain in the early stages of penetration with roughly 1% share. We see a clear path to building a significantly larger business with our growing suite of AI powered solutions, expanding market share, and increasing average revenue per location. Moving to our financial results starting with the fourth quarter we produced sixty three point four million dollars in total revenue which represents 17 percent year-over-year growth driven by payments in the addition of new locations gross margin for the quarter was seventy three point three percent representing a year over year improvement of 70 basis points we have delivered sequential gross margin expansion in 15 of the past 16 quarters, including a 30 basis point sequential improvement in Q4. Margin improvement was primarily driven by ongoing efficiencies in our cloud infrastructure and amortization of phone hardware and payment terminals as devices older than three years become fully amortized. We also continue to benefit from the growing contribution of higher margin payments revenue. Total operating expenses for Q4 were 70% of revenue. General and administrative expenses were 9.6 million dollars and provided the most year-over-year operating leverage improvement in our business. General and administrative expenses improved to 15% of revenue from 17% in Q4 2024, a a decrease of over 200 basis points. Research and development expenses were $8.9 million or 14% of revenue, which represents a decrease from 15% in Q4 2024. Sales and marketing expenses totaled $25.6 million or 40% of revenue. As discussed in previous earnings calls, we made a number of targeted investments in 2025. We added sales capacity in mid-market. We grew our upsell team to increase product attach rates, including payments through a new dedicated payment sales team. And we built out a channel sales team that focuses exclusively on selling through commercial partnerships. We also increased our marketing program spend to increase brand awareness and demand in the specialty medical vertical and in promoting our AI receptionist and new products. Mid-market and specialty medical sales accelerated in 2025 and we finished the year with strong sales performance and a healthy pipeline to start 2026 behind these investments. We continue to optimize our sales and marketing efforts and anticipate some improvements in sales and marketing efficiency in the second half of 2026. Operating income for the quarter was $2.3 million, an improvement of over $500,000 compared to Q4 2024. This represents an operating margin of 3.6%, a 30 basis point improvement over the prior year and a 90 basis point improvement sequentially. Turning to the balance sheet and cash flow, we continue to see strong liquidity and free cash flow. We ended the quarter with $81.7 million dollars in cash and short-term investments, an increase of $1.4 million dollars sequentially. Cash provided by operating activities in Q4 was $6.2 million dollars and free cash flow was $4.4 million dollars. Free cash flow for the full year was $12.9 million dollars which represents 24% year over year growth. Our net revenue retention rate in Q4 was 93%. Our gross revenue retention rate was 89% and remains very strong for companies serving SMB customers. As a reminder, our reported retention rates are a weighted average of the previous 12 months' retention rates. As such, it can take several quarters for the progress we are currently making to show through our reported retention metrics. I will provide additional one-time metrics in this year-end recap, which we believe may be helpful in understanding 2025 retention rate trends. First, when looking at gross retention, we implemented a number of initiatives in 2025 that improved the customer experience, including more tailored onboarding, new products and refined product packaging, which along with greater integration coverage and depth across all verticals, helps ensure customers receive the value they expect. These efforts yielded a steady reduction in churn in the second half of 2025, and Q4 churn returned to our 2023 and 2024 churn levels. We expect gross revenue retention rates to trend back to historical ranges of 91% to 93% over time. Previously we highlighted how integrations with practice management systems affect churn. Users who purchase Weave products that are not yet integrated with practice management systems or that have basic read-only integrations typically have higher initial churn rates. New verticals like specialty medical typically start with higher churn rates, which improve over time as we increase the number and depth of practice management integrations. Additionally, we have seen an ongoing trend of single locations being acquired by larger groups. While we may lose single locations to multi-location groups through acquisition, our investments in mid-market and AI, combined with high customer satisfaction rates, position us to potentially win those businesses back as part of a larger deal. Transitioning to net revenue retention rates, we discussed previously that our net revenue retention rate in the first half of 2025 was bolstered by the effects of a price increase in 2024, which accounted for approximately 250 basis points of uplift. We lapped the effect of that price increase in the first half, and our net revenue retention rate has subsequently decreased accordingly. It's also important to note that our reported retention metrics are measured on a location basis, not on a customer or logo basis. Approximately two-thirds of our current customer base is single location practices. The addition of another location within a multi-location customer does not improve our net revenue retention rate. Looking solely at multi-location groups on a logo basis our net revenue retention rate is a hundred and two percent while our net revenue retention rate is ninety three percent for single location practices multi locations have a higher net revenue retention rate on a logo basis because of location additions my final point is that our ability to expand net revenue retention has been limited because customers often adopt most of our products we up front customers often consolidate multiple point solutions when they purchase weaves unified platform this establishes higher initial revenue capture though this historically limited our near-term upsell opportunities we have seen this dynamic reflected in average revenue per location growth which grew 10% over the past two years even as net revenue retention declined over the same period. However, the addition of Truelark and faster product development cycles are now meaningfully expanding the upsell opportunity within our installed base. Our insurance eligibility and Truelark products drove acceleration of upsells in Q4 and our penetration into the installed base for both products is still less than 2%. We ended 2025 with 39,625 active customer locations, an increase of 4,628 locations year over year. Before turning to our outlook, I'll briefly recap full-year performance. For 2025, total revenue grew 17% to $239 million. Gross margin for the year expanded to 72.7% up 80 basis points from 71.9% in the prior year. We delivered full-year operating income of four point one million dollars representing an operating margin of 1.7% compared to 0.4% last year. This marks another year of progress and profitability and I would like to highlight that this year's improvement came while also making targeted investments in growth initiatives which reflects our ability to balance growth while making investments into our business. We are pleased with our progress this year would like to thank our team members at Weave our customers and partners for their contributions throughout the year. Looking ahead we remain encouraged by the strengthening foundation of the business and the opportunities in front of us for the first quarter of 2026 we expect total revenue to be in the range of sixty four point two million dollars to sixty four point eight million dollars we expect to improve first quarter operating income year over year and for it to be in the range of one million dollars to two million dollars as a reminder there are seasonal factors that result in a sequential increase in in expenses in Q1, including the reset of payroll tax limits, benefit renewals taking effect, and the timing of the annual audit fees, which are weighted more heavily in Q1. We remain committed to delivering improving margins while maintaining our bias toward growth. We are beginning to benefit from the investments made in 2025, such as those made in sales and marketing, and we will be flowing an increased percentage incremental revenue into operating income in 2026 for the full year 2026 we expect to grow total revenue to be in the range of 273 million dollars to 276 million dollars with the new products brett discussed which will be released throughout the year we expect the impact of these products to positively impact revenue growth in the latter half of the year we also expect to improve non-gap operating income year over year to be in the range of 8 million dollars to 12 million dollars we expect our weighted average share count for q1 to be approximately 78.7 million shares and approximately 79.9 million shares for the full year in closing i share brett's excitement about our 2026 roadmap and our position in the market we delivered a strong 2025 marked by solid revenue growth, continued margin expansion, and improving profitability and cash generation. We remain confident in our strategy and our ability to execute as we continue to balance growth and profitability improvements. With that, I'll turn the call over to the operator for Q&A.

We will now begin the question and answer session. If you would like to ask a question, a reminder to please raise your hand now. If you have dialed into today's call, please press star nine to raise your hand, star six to unmute. Please stand by as we compile the Q&A roster. And our first question comes from Parker Lane of Stiefel. Your line is open. Please

go ahead. This is Matthew Kickert for Parker. Thank you for taking my questions. To start, can you talk a little bit more about the care credit integration that you announced this morning? Just curious if that's your focus, is to drive incremental payments attached rate, more average payments volumes across existing customers or something else?

Yeah. Great to catch up with you, Matthew. The CareCredit partnership, what that really does is open up another avenue for us to capture volumes that otherwise would flow through CareCredit themselves. They are the largest provider of patient financing solutions in the market and this gives us access through the partnership to some of the volumes that otherwise would flow through them so there's work now to be done on the the integration and bringing that directly to market so today we just announced that we completed the partnership and we'll have more color to provide in the future and I would add you know this is kind of just a next

step in our payment strategy so you know kind of starting with basic payment processing then moving into more additional financial tools additional financial vehicles you know that allow our customers to offer their patients so it makes our takes our payment solution to basically a financial solution and the practices have more tools to offer their patients whether it be financing through care credit, financing through themselves, using the weave tools to schedule payments. So it just makes the payment product more attractive, stickier, in addition to attaching

more volume. Okay. And then secondly, for 2026, what are your expectations for growth rates across

the different sub-riticals? Yeah. You know, we're starting the year in a great position. We haven't broken out the growth rates for each one of the different the verticals that we serve but we continue to we continue to anticipate strong growth across the growth vectors that we've talked about around specialty medical we just talked about how q4 was our strongest strongest quarter from from from an from an additions perspective there. Mid-market grew nicely in 2025. We expect that to continue. Can't speak to the underlying components, but we do anticipate to continue to see momentum and grow through the same channels.

Yeah, and I would add, expect, especially Medical probably will be the strongest grower just because of the opportunities set here and all the work that we've done on adding integrations throughout this year, continue to add them throughout the year. Some of the marketing dollars that you saw that we spent in Q4 is really around developing our brand presence in that sector. So we expect that to grow, continue to be the fastest grower. I expect all of our verticals to grow nicely. The omnichannel AI receptionist that we're rolling out is really valuable to kind of all verticals and integrated and not. I mean, the tool is quite useful even without a PMS integration. So I think I expect solid growth in all verticals, but I think specialty medical will probably lead the pack.

Perfect. Thank you.

And your next question comes from the line of Alex Sklar with Raymond James. Your line is open. Please go ahead. We'll move on to our next question from Hannah Rudolph of Piper Sandler. Your line is open. Please go ahead.

Thanks for taking my questions today. It was encouraging to hear that stat about the one customer, I believe you said, who scheduled 1,200 appointments using your AI receptionist. I guess longer term as you think about it and you launch more AI capabilities and you complete the rollout of this unified inbox, how do you think about pricing to capture the value that you're delivering?

Yeah, so we will definitely be able to monetize it. I think still being worked out is, is it priced as an additional module or is it priced as, you know, included in a bundle? So, for example, you know, you may have standalone Trulark now, and if you want to go to the Fusion inbox where that brings everything from Trulark and we all together in one place, which is the ultimate destination, is that a premium product that we price for? The really important concept, though, is that we're now going ability to attach to the labor budget because we can just prove how we save labor and how we drive revenue. So we're very confident that we can monetize the additional AI omnichannel receptionist functionality, and I think we'll work it out over time. I think a really important point is we don't license by seat. we license by location and then consumption and we're confident that these tools will produce a lot of value for the practices and we'll be able to monetize them accordingly totally makes sense

and then jason i really appreciate the additional color you gave this quarter round nrr and the multi-location nr are you shared i guess you've you've talked about churn being higher and average sales prices being lower initially in some of your newer verticals as you know you have newer integrations and some some of the solutions are non-integrated i guess have you seen these metrics stabilized for some of your oldest specialty medical cohorts or does that take longer than a few years to kind of stabilize and average with historical metrics yeah thank you for the question

you know we saw the same phenomenon i highlighted how we saw uh churn decrease through the second a half of the year in Q4 returned to 2023-24 rates, you know, we saw a nice improvement in specialty medical as well in Q4, and so we've already started to see some of the improvements there. We've delivered a number of integrations on that front. We've expanded our coverage on that front, so as those have started to mature, we're encouraged about making that that declaration about where churn will will trend back towards because we're already starting to see some of the proof points

there that we've been talking about yeah and I would add Hannah you mentioned does it you know does it get better over over years and it's actually happens more quickly than that we're seeing it improve over quarters and it's just as you as you get your you know improve your integrations depth breadth turn rates come down and and not only do turn rates to come down but but cat comes down over time as you develop a brand you have more word-of-mouth you're more familiar in the trade shows so it's it's a it's a virtuous benefit that that comes over trends over time and then if you say well you know how do you know that it's it's just um you know from our history looking through all of our verticals that we enter and and that's one of the reasons we do it as a step function as opposed to just you know doing a shotgun blast with a lot of verticals because the idea is you know you go into initial vertical asp is lower cac is higher churn is higher you work through that asp comes up cac comes down churn comes down and then you kind of go into a new vertical and you kind of just stage it that way And I've been in vertical SaaS and payments for over a decade, and this is the pattern I've seen throughout that entire period.

Great. Really encouraging to hear. Thank you, guys.

And we will come back to Alex Sklar for your next question from Raymond James. Your line is open. Please go ahead. A reminder that it is star six to unmute. Okay, we will move on to Mark Chappelle with Loop Capital. Mark, your line is open. Please go ahead.

hi uh good afternoon uh can you hear me okay yes yes we can okay great super so thanks for taking my question uh but starting with you i was wondering if you just kind of walk through uh your investment priorities and also hiring priorities for the coming year sure so um

i think they're the same our investment priorities and our hiring priorities um so that's that's good i i think number one on our hiring and investment priorities are product and engineering um we we've got a really unique advantage with since we we own the telephony stack we have the practice phone number we have the data we are really uniquely positioned to to take, you know, the AI receptionist technology from a text experience to, you know, kind of a native inside of Weave and then make it a full voice experience. And so we are really leaning hard into that and investing against hiring engineers and product people to make sure that we can execute effectively on that one. I think, you know, other investment priorities are on the GTM side, go-to-market side, and we've actually made a couple changes to our model at the end of this year and into next year. We used to have a full-service AE model, and now we're kind of moving more to an SDR AE model. It's more efficient, and it seems to be working, so early proof points are good there. And I think those are the big investments we're making, certainly in the first half of the year.

Okay, great. Thank you. And then as a follow-up, you know, some of your competitors are also highlighting AI in their products. I was wondering if you could just talk a little bit about how Weave is either differentiating or plans to differentiate its AI animation capabilities from those of your competitors.

sure so you know we see lots of um companies who are you know some some have some products some just put ai on their website um i think our unique well i know our unique differentiators are you know kind of what i said what i started with is we own the telephony stack um we've got the trusted relationships and we own the very specific complex industry you know industry specific workflows we're a trusted partner of these businesses and they really you know I meet with customers and they'll show me all the products they have and they said what which of these can weave do please they really want to consolidate functionality so the idea of saying for example having an AI chat bot up in one window and weave up in another window and a PMF's in another window it just doesn't work great and so we have the opportunity to bring all of those workflows together and because we have the full experience we can retain context through the whole discussion so you may start with a text or you may start with a call and then the call transitions to text and then the text maybe gets escalated to a specific person and the staff who can handle only specifically handle that question all of that interaction whether it's voice or text gets retained in one place and it also gets analyzed by our we've call intelligence so then you can create action items you can create tasks you can actually perform work whether it be issuing an invoice filing and checking on insurance verification booking an appointment rescheduling an appointment so having all you know the deep integrations the deep workflows the The subject matter expertise, the relationships, and the ability to kind of have seamless handoff is a real, real differentiator. These highly specific workflows are hard and you have to learn them over time. If you get an appointment wrong, so for example, someone wants a crown done and you book a 30-minute appointment for a cleaning that really hurts the practice's day and so having that knowledge that experience you know we've got billions of these interactions and we know kind of over time what type of calls result in what type of outcomes and we can optimize practice operations using that that knowledge and that deep expertise thank you and we will come

come back one more time to Alex Sklar with Raymond James. Your line is open. Please go ahead.

Hi, Alex. All right. Thanks. It's like third time's a charm. This is actually John on for Alex. Brett, maybe we'll start with payments here. It's great to hear about the continued strength in payments. It's been a nice growth driver for you. I'm curious, though, any comments you can share on growth differences you're seeing by end market, and then maybe how we should think about payments growth and payments attach rate in 2026 and over the medium term then I have a quick

follow-up right so I can give you some product growth highlights and maybe Jason can talk about sectors so we released this year a couple of really cool new features bulk collection but but surcharging surcharging has been very very well received it's a great upsell product and And that is actually driving some pretty reasonable, almost significant volume growth from the new customers who adopt it. And of course, surcharging is your ability to charge the patient for the credit card fee. And so that gets us not only a better take rate, but more importantly, it just gets us more volume. So that's in early stages, but we're seeing some very nice green shoots on that one. And I'll let Jason talk about sectors.

Yeah, so some of the, I think one of the best ways to think about payments in the sectors and how it differentiates for us is, when you think about the economics of a practice, the average dentist within a practice will do about a million dollars in gross billings a year. And about 50 to 60% of that will go through an insurance process, so the remaining 40, 50% is our opportunity to go after that. So when we think about going after, or the performance in different sectors, what's really important is to understand what the insurance component within each one of the sectors we go after or that we sell to have, Have and what just the nature of their economics are and so like it's in specialty medical when you're dealing with primary care You're dealing with significantly higher insurance coverage rates and so the payments opportunity for us in that space isn't as great as it is in like aesthetics or in veterinary and so we try to align our our go-to-market efforts with the needs of those those industries, and the opportunity for us to expand revenue per location through them. So that's how we think about the different specialties, and it's a contributing factor. Brett talked about how we approach the different specialties and the next verticals in a step function. We look at the overall economics of those specialties as we decide what are the next specialties or the next verticals that we open up. And it's something we consider there across all the different solutions that we offer.

That was great color there. And then, Jason, maybe just a follow-up on the NRR improvements. I know it's been touched on in earlier questions, but specifically I do want to understand how additive you think some of the newer products, like the Trulark and your organic product expansion can be to NRR growth in 2026 and maybe over the medium term, kind of what's

embedded in the guide there thanks yeah so the first what's embedded within the guide a lot of the growth from the ai receptionist follows the timeline and the roadmap that brett laid out in his remarks so it it's biased more towards the second half just based on the timeline for when those products roll to general availability um you know i think the the opportunity for growth is is really strong from a net revenue retention perspective. We're still in the early days of selling that. The impact it'll have, I guess I'm not ready to provide a lot of color on that today. There's a significant upsell opportunity, but we also know that customers have typically landed heavy whenever we bring these new capabilities, which could lead to further average revenue per location expansion without necessarily leading to significant net revenue retention expansion. And so I guess I'd like to let the dynamics play out a little bit more as we get more sales experience there, but the opportunity is quite significant and really encouraging.

Can I, let me just add a little bit more color to the earlier question about you know why we stands out as having an advantage and as we knew move to these omnichannel AI receptionists and and you know there's a bunch of them out there you know in addition to the things I mentioned like domain expertise a really important one is frankly our scale and the fact that you know because we're a public company because we have scale we have to do it right so when it comes to data you know maintaining the data security maintaining and ensuring that the data is used properly compliance you know we've got HIPAA we've got PHI we've got PCI we've got all these rules and that we have to comply with and you know reliability and scalability and security and you know being able to support the full experience front to back these are just a lot of things that buyers are becoming more and more concerned about, especially large groups, that some of these smaller, kind of newer businesses just don't have the scale or the financial ability to comply with, or frankly, it's probably not as much of a focus for them. And for us, it's just absolutely table stakes.

There are no further questions at this time. I will now turn the call back to Brett White for closing remarks.

Well, thank you all for joining the call. We're super excited about 2026. And thank you again to the entire WEAVE team for posting an incredible 2025. Thank you.

This concludes today's call. Thank you for attending. You may now disconnect.